Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell Deficiency

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2020

Study Completion Date

March 11, 2022

Conditions
Limbal Stem Cells Deficiency
Interventions
PROCEDURE

Biopsy from donor eye

Corneal biopsy from undamaged limbus

PROCEDURE

Implant of Holoclar

Implant of Holoclar into the eye to be treated after scraping of the fibrovascular pannus

PROCEDURE

Ophtalmologic examination

"The following assessments are performed:~Epithelial defects assessment by fluorescein staining; superficial corneal neo-vascularization assessment; Best-Corrected Visual Acuity; ocular tonometry; slit lamp examination (both corneal endothelium and anterior chamber); conjunctival inflammation (both bulbar and limbal) assessment; corneal sensitivity and involvement assessment; Schirmer's test type I; evaluation of the following symptoms: pain, burning, photophobia."

PROCEDURE

Blood sample collection

Standard haematology, biochemistry and Infectious profile (Virology) are assessed

PROCEDURE

Digital pictures

At least 4 digital corneal slit lamp photos without fluorescein and at least 4 digital corneal slit lamp photos with fluorescein are taken using digital camera

PROCEDURE

ECG

A 12-lead ECG measurement in single recording at screening for safety reason and before each transplantation.

BEHAVIORAL

Questionnaires

Quality of Life assessment through the NEI VFQ 25and EQ-5D-3L questionnaire (EQ-5D-Y in paediatric population)

PROCEDURE

Physical examination and vital signs

A complete physical examination and vital signs (Systolic and Diastolic Blood Pressure (SBP, DBP) and Pulse Rate (PR) must be assessed at each visit (but not at pre-screening and at visit 6)

Trial Locations (1)

20100

Hospital San Raffaele, Milan

All Listed Sponsors
lead

Holostem s.r.l.

INDUSTRY

NCT02577861 - Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell Deficiency | Biotech Hunter | Biotech Hunter